Last $15.01 USD
Change Today +0.32 / 2.18%
Volume 691.7K
VNDA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James Patrick Kelly

Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary, Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48$1,145,378
As of Fiscal Year 2013

Background*

Mr. James Patrick Kelly, also known as Jim, has been the Chief Financial Officer, Senior Vice President, Secretary and Treasurer at Vanda Pharmaceuticals, Inc. since December 13, 2010 and also serves as its Principal Accounting Officer. Mr. Kelly has more than 18 years of experience in financial and operating roles within the healthcare and pharmaceutical industry. He has been a key member of MedImmune's financial leadership team since 2006. He joined MedImmune LLC., ...

Read Full Background

Corporate Headquarters*

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Cornell University
BS
The University of Vermont

Other Affiliations*

Annual Compensation*

Salary$315,000
Total Annual Compensation$315,000

Stock Options*

Restricted Stock Awards$231,800
All Other Compensation$21,234
Exercisable Options175,779
Exercisable Options Value$1,004,122
Unexercisable Options146,721
Unexercisable Options Value$612,203
Total Value of Options$1,616,325
Total Number of Options322,500

Total Compensation*

Total Annual Cash Compensation$493,734
Total Short Term Compensation$315,000
Other Long Term Compensation$253,034
Total Calculated Compensation$1,145,378
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $15.01 USD +0.32

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Masayo Tada Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.